Pregnancy-Associated Spontaneous Coronary Artery Dissection: Why This iSCAD Registry Report Matters
Spontaneous coronary artery dissection, or SCAD, is now recognized as an important non-atherosclerotic cause of acute coronary syndrome and myocardial infarction, particularly in women. Among its clinically challenging forms is pregnancy-associated SCAD (P-SCAD), a rare but potentially catastrophic event that can occur during pregnancy or the postpartum period. The iSCAD Registry report focuses on a crucial gap in the literature: the reproductive, demographic, psychosocial, and event-related features of women with prior pregnancy history who experienced SCAD.
This study is important because pregnancy is a uniquely dynamic cardiovascular state. Hemodynamic stress, hormonal shifts, vascular remodeling, and postpartum physiologic changes may all contribute to vulnerability in susceptible women. Yet until recently, detailed reproductive data in SCAD cohorts have been sparse. That limitation has made it difficult for clinicians to counsel patients accurately regarding pregnancy planning, postpartum risk, and long-term reproductive health after SCAD.
Study Context and Clinical Relevance
SCAD often affects women who do not fit the classic atherosclerotic coronary disease phenotype. Patients may be younger, otherwise healthy, and present with myocardial infarction symptoms that can be misattributed to anxiety, musculoskeletal pain, or benign postpartum discomfort. In pregnancy-related cases, diagnostic delay can be especially dangerous because both maternal and fetal outcomes may depend on rapid recognition and coordinated cardiovascular care.
Pregnancy-associated SCAD is also clinically relevant because it raises questions that extend beyond the acute event. Should women with prior SCAD be counseled against future pregnancy? Which reproductive features are more common among those who experience P-SCAD? Are there psychosocial differences that may influence access to care, symptom reporting, or recovery? The iSCAD Registry study attempts to answer these questions in a multicenter observational framework.
Study Design and Population
This was a cohort study using data from the iSCAD Registry between 2019 and 2024. The investigators compared women with pregnancy-associated SCAD to women with non-pregnancy-associated SCAD (NP-SCAD), focusing on those with a history of at least one prior pregnancy. In addition to registry data, the study examined rates of selected reproductive health features in the general reproductive-aged population across US states, providing a broader epidemiologic context.
The analysis used the Kruskal-Wallis test for continuous variables and the chi-square test for categorical variables. These methods are appropriate for descriptive group comparisons in observational registry data, although they do not establish causality. The study design is best interpreted as hypothesis-generating and clinically descriptive rather than definitive for risk prediction.
Key Findings
The central contribution of this report is its detailed characterization of women with P-SCAD compared with those with NP-SCAD. While the abstract emphasizes that the study examined demographic, psychosocial, and SCAD-event factors, the broader clinical implication is that pregnancy-associated cases are not merely a timing variant of SCAD; they may represent a subgroup with distinctive reproductive and potentially contextual risk features.
One important theme is that P-SCAD appears to be uncommon but disproportionately consequential. Even in a registry enriched for SCAD cases, pregnancy-associated events remain a minority, reflecting the rarity of the condition. However, rarity should not be mistaken for clinical irrelevance: because P-SCAD occurs in women during a period when both maternal health and family planning decisions are acutely important, each case carries outsized clinical and psychosocial impact.
The study’s focus on reproductive variables is especially valuable. Traditional cardiovascular registries often overlook obstetric history, lactation status, pregnancy spacing, fertility treatment, parity, and timing relative to delivery, despite their potential relevance. By integrating reproductive data with psychosocial and event-related features, the iSCAD Registry helps move the field toward a more holistic understanding of disease expression in women.
Although the abstract does not provide detailed effect sizes, the design implies that the investigators compared P-SCAD and NP-SCAD groups across multiple domains. Clinically, such comparisons matter because they may reveal patterns useful for risk stratification or counseling, such as differences in age at event, timing of SCAD in relation to pregnancy, history of obstetric complications, and psychosocial burden. These features can inform the content of shared decision-making discussions when women with a history of SCAD ask about future pregnancy.
The comparison with reproductive-aged women in the general population adds another layer of interpretation. If certain reproductive characteristics are overrepresented among women who develop P-SCAD, that could suggest associations worth studying further. Alternatively, if the reproductive profiles are similar to those of the general population, the key trigger may be pregnancy itself acting on a susceptible vascular substrate rather than a distinct reproductive phenotype. Either scenario would be informative, but both require cautious interpretation because registry comparisons are vulnerable to selection and reporting biases.
Clinical Interpretation
From a clinical standpoint, the most actionable message is that pregnancy-associated SCAD should remain on the differential diagnosis for pregnant and postpartum women with ischemic chest pain, dyspnea, diaphoresis, presyncope, or unexplained hemodynamic instability. The diagnosis is often delayed because clinicians may assume that cardiovascular symptoms in young women are low probability for coronary disease. The consequences of that assumption can be severe.
The study also reinforces the need for multidisciplinary care. Management of women with P-SCAD does not stop after discharge from the coronary care unit. It may require coordination among cardiology, maternal-fetal medicine, primary care, mental health professionals, and sometimes genetics or vascular medicine specialists. Reproductive counseling is especially important, because the psychological burden of prior SCAD can be substantial and because the decision to pursue another pregnancy can be medically and emotionally complex.
In this context, psychosocial variables are not secondary details; they are core outcome modifiers. Anxiety, post-traumatic stress symptoms, fear of recurrence, and uncertainty about future fertility can all influence recovery and long-term quality of life. By including psychosocial characteristics, the iSCAD Registry aligns with a modern view of cardiovascular disease in women: one that incorporates lived experience as part of the disease burden.
Strengths of the Study
This report has several strengths. First, it uses a multicenter registry, which is appropriate for a rare condition like SCAD. Randomized trials are not feasible for studying spontaneous dissections, so well-constructed observational registries are essential for advancing knowledge. Second, the emphasis on reproductive health variables addresses a major evidence gap. Third, the comparison with reproductive-aged women in the general population helps contextualize observed patterns beyond the SCAD cohort itself.
Another strength is the broad scope of variables considered. By examining demographics, psychosocial factors, and event-related features alongside reproductive history, the study moves beyond a narrow cardiovascular lens. This is particularly important in women’s cardiovascular health, where biological, reproductive, and psychosocial domains often interact.
Limitations and Areas of Caution
As with all registry-based studies, interpretation must be cautious. The abstract does not provide detailed sample size, event adjudication criteria, or the full distribution of reproductive variables, which limits precision in interpreting the magnitude of differences between groups. Observational comparisons are also subject to confounding. Women with P-SCAD may differ from those with NP-SCAD in age, health system access, referral patterns, or recall of reproductive history.
There is also the possibility of selection bias. Registry participants may not represent all women with SCAD, particularly those treated in smaller centers or those not engaged with specialty follow-up. Reproductive histories may be incomplete or subject to recall error, especially if events occurred years earlier. Additionally, the comparison with general population reproductive-aged women across US states may be limited by differences in data source, measurement definitions, and temporal alignment.
Finally, the study design cannot determine whether pregnancy itself causes SCAD or whether it unmasks a predisposition in women with underlying arteriopathy or vascular fragility. In clinical practice, this distinction matters less than the recognition that pregnancy and the postpartum period can be high-risk windows for susceptible patients. But scientifically, it remains a key unanswered question.
Implications for Practice
For clinicians, the take-home message is straightforward: P-SCAD is rare, but it should be recognized early, managed aggressively, and followed longitudinally. Women with a history of SCAD who are considering pregnancy should receive individualized counseling that integrates cardiac history, ventricular function, residual ischemia, vascular comorbidities, medication exposure, and the patient’s values and reproductive goals.
For obstetric clinicians, the study reinforces the importance of cardiovascular vigilance during pregnancy and postpartum care, particularly in women with prior SCAD or unexplained chest pain. For cardiologists, it underscores the need to ask reproductive questions routinely, because pregnancy history may inform both diagnosis and counseling. For health systems, it suggests a need for structured care pathways and registry infrastructure to improve surveillance and patient-centered outcomes.
Conclusion
The iSCAD Registry report advances the field by highlighting pregnancy-associated SCAD as a distinct and clinically meaningful subgroup within the SCAD spectrum. Its emphasis on reproductive variables, psychosocial context, and event characteristics helps fill a critical evidence gap and supports more nuanced counseling for affected women.
While registry data cannot establish causation, they can identify patterns that guide future research and inform bedside care. The practical message is clear: pregnancy-associated SCAD deserves heightened diagnostic suspicion, multidisciplinary management, and carefully individualized reproductive counseling. As the evidence base grows, the goal should be not only to improve survival after SCAD, but also to help women make informed, safe decisions about future pregnancy and long-term cardiovascular health.
Funding and ClinicalTrials.gov
The abstract provided does not specify funding sources or a ClinicalTrials.gov registration number. These details should be confirmed in the full article.
References
1. Hayes SN, Tweet MS, Adlam D, et al. Spontaneous coronary artery dissection: JACC state-of-the-art review. J Am Coll Cardiol. 2020;76(8):961-984.
2. Tweet MS, Hayes SN, Pitta SR, et al. Clinical features, management, and prognosis of spontaneous coronary artery dissection. Circulation. 2012;126(5):579-588.
3. Adlam D, Alfonso F, Maas A, Vrints C. Management of spontaneous coronary artery dissection: a review of the literature and practical recommendations for the clinician. Eur Heart J. 2018;39(18): 1529-1538.
4. American Heart Association scientific statement on spontaneous coronary artery dissection. Circulation. 2018;137(19):e523-e557.
Article Structure Plan
1. Title
2. Highlight
3. Study background / disease burden
4. Study design
5. Key findings / results
6. Expert commentary
7. Conclusion / summary
8. Funding and ClinicalTrials.gov
9. References
